Peter J Parker
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 13, 2023
Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.Tanya N Soliman, Daniel Keifenheim, Peter J Parker
|Feb 23, 2023
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer.Lissete Sánchez-Magraner, Juan Gumuzio, James Miles
|Nov 12, 2020
Equivocal, explicit and emergent actions of PKC isoforms in cancer.Peter J Parker, Sophie J Brown, Veronique Calleja
|Mar 16, 2019
The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity.Ahmed Elbediwy, Yixiao Zhang, Mathias Cobbaut
|May 02, 2018
Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface.Jeroen Claus, Gargi Patel, Flavia Autore
Pageof 1
Frequent Collaborators
3 joint publications
Tanya Soliman
2 joint publications
Mathias Cobbaut
1 joint publications
Selene Roberts
1 joint publications
Paul R Barber
1 joint publications
Ray S Tan
1 joint publications
Jacqueline J T Marshall
1 joint publications
Lissete Sánchez-Magraner
1 joint publications
Juan Gumuzio
1 joint publications
Carmen Etxezarraga
1 joint publications
Kim van Elst
